合法的大麻のオーストラリア市場2020-2026:製品種類別(マリファナ、麻油)、用途別

◆英語タイトル:Australia Legal Cannabis Market Size, Share & Trends Analysis Report By Product Type (Marijuana, Hemp Oil), Application (Adult Use, Medical, B2B Channel), And Segment Forecasts, 2020 - 2026
◆商品コード:GV20JN002
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年5月
◆ページ数:80
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2週間)
◆調査対象地域:オーストラリア
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Australia Legal Cannabis Market Growth & Trends
The Australia legal cannabis market size is expected to reach USD 1.9 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 42.1% during the forecast period. Increasing government support for marijuana legalization, rising patient population, and the entry of international companies in the country are the key factors driving the market growth. An increase in the production of medical marijuana owing to its high demand in the pharmaceutical sector is anticipated to further drive the growth.

In 2019, the marijuana segment dominated the market for legal cannabis, with a revenue share of 71.3%. The segment is further classified into flower and oil. The flower segment dominated the market in 2019, owing to its high availability and adoption among consumers. On the other hand, the oil segment is projected to be the fastest-growing, due to rising consumer awareness about the negative effects of marijuana smoking. Moreover, the preference for marijuana oil is increasing among patients, as it is easy to ingest and more travel friendly.

Medical application dominated the market in 2019. A steep rise in the number of medical approvals for patients, on-going research on cannabis, and increased production are the key factors driving the market growth. Furthermore, its sub-application-chronic pain-dominated the market with market size of USD 55.2 million in 2019. Increasing demand for effective pain management therapeutics is the key factor driving the segment growth.

Australia Legal Cannabis Market Report Highlights

• Marijuana product type dominated the market in 2019, with a revenue share of 71.3%, owing to its high adoption and availability

• Chronic pain, under medical applications, dominated the market in 2019 with a value of USD 55.2 million, as the demand for cannabis is increasing in pain management

• The market is dominated by many local and international players. Local players are focused on geographical expansion and creating awareness about the medical benefits of marijuana among patients and healthcare professionals for increasing their consumer base

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.2 Research Methodology
1.2.1 Information Procurement
1.3 Information or Data Analysis
1.4 Market Formulation & Validation
1.4.1 Australia Legal Cannabis Market: CAGR Calculation
1.5 List Of Secondary Sources
1.6 List Of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot, Revenue (USD Million)
Chapter 3 Market Variables, Trends & Scope
3.1 Penetration & Growth Prospect Mapping
3.2 Australia Legal Cannabis Market Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Rising patient population
3.2.1.2 Increasing legalization of cannabis
3.2.1.3 Entry of international players
3.2.2 Market Restraints Analysis
3.2.2.1 Stringent regulations on hemp usage
3.2.2.2 Increasing illicit cannabsi trade
3.2.3 Industry Challenge
3.3 Regulatory Framework
3.3.1 Australia
3.3.1.1 Cultivation/Production
3.3.1.2 Legal Status of Cannabis Derived Products
3.3.1.3 Regulatory Bodies Involved
3.3.1.4 Import/Export Scenario
3.4 Australia Legal Cannabis Market Market Analysis Tools
3.4.1 Australia Legal Cannabis Market Market – PESTLE Analysis
3.4.2 Industry Analysis – Porter’s
3.5 Opportunity Analysis (2016-2019-2026)
3.6 Value Chain Analysis
3.6.1 Raw Materials Trends
3.6.1.1 Market price evolution of biomass commodity cost (to processor)
3.6.2 Manufacturing Trends
3.7 Medical Cannabis Users Pool Analysis, 2016 – 2026
Chapter 4 Australia Legal Cannabis Market Market: Product Type Market Estimates & Trend Analysis
4.1 Australia Legal Cannabis Market Market: Product Type Analysis
4.1.1. Marijuana
4.1.1.1 Marijuana market, 2016 – 2026 (USD Million)
4.1.1.2 Flower
4.1.1.2.1 Flower market, 2016 – 2026 (USD Million)
4.1.1.3 Oil
4.1.1.3.1 Oil market, 2016 – 2026 (USD Million)
4.1.2 Hemp oil
4.1.2.1 Hemp oil market, 2016 – 2026 (USD Million)
Chapter 5 Australia Legal Cannabis Market Market: Application Type Market Estimates & Trend Analysis
5.1 Australia Legal Cannabis Market Market: Application Type Analysis
5.1.1. Adult use
5.1.1.1 Adult use market, 2016 – 2026 (USD Million)
5.1.2 Medical
5.1.2.1 Medical use market, 2016 – 2026 (USD Million)
5.1.2.2 Chronic Pain
5.1.2.2.1 Chronic pain market, 2016 – 2026 (USD Million)
5.1.2.3 Anxiety
5.1.2.3.1 Australiaanxietymarket, 2016 – 2026 (USD Million)
5.1.2.4 Inflammation
5.1.2.4.1 Inflammation market, 2016 – 2026 (USD Million)
5.1.2.5 Sleep Disorder
5.1.2.5.1 Sleep Disordermarket, 2016 – 2026 (USD Million)
5.1.2.6 Others
5.1.2.6.1 Other applicationmarket, 2016 – 2026 (USD Million)
5.1.3 B2B Channel
5.1.3.1 B2B channel market, 2016 – 2026 (USD Million)
Chapter 6 Competitive Landscape
6.1 COMPANY PROFILES
6.1.1 AusCann Group Holdings Pty Ltd
6.1.1.1 Company overview
6.1.1.2 Financial performance
6.1.1.3 Product benchmarking
6.1.1.4 Strategic initiatives
6.1.2 Cann Group Ltd
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Product benchmarking
6.1.2.4 Strategic Initiatives
6.1.3 Bod Australia
6.1.3.1 Company overview
6.1.3.2 Financial performance
6.1.3.3 Product benchmarking
6.1.3.4 Strategic initiatives
6.1.4 Zelira Therapeutics
6.1.4.1 Company overview
6.1.4.2 Financial performance
6.1.4.3 Product benchmarking
6.1.4.4 Strategic Initiatives
6.1.5 Althea Group Holdings Limited
6.1.5.1 Company overview
6.1.5.2 Product benchmarking
6.1.5.3 Product benchmarking
6.1.5.3 Strategic Initiatives
6.1.6 THC Global Group Limited
6.1.6.1 Company overview
6.1.6.2 Financial performance
6.1.6.3 Product benchmarking
6.1.6.4 Strategic Initiatives
6.1.7 MGC Pharmaceuticals Ltd
6.1.7.1 Company overview
6.1.7.2 Financial performance
6.1.7.3 Product benchmarking
6.1.7.4 Strategic Initiatives
6.1.8 Ecofibre Limited
6.1.8.1 Company overview
6.1.8.2 Financial performance
6.1.8.3 Product benchmarking
6.1.8.4 Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviation
Table 3 Australia Medical Cannabis User Pool Analysis, 2016 - 2026


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[合法的大麻のオーストラリア市場2020-2026:製品種類別(マリファナ、麻油)、用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆